vs
CoStar Group（CSGP）与Evolent Health, Inc.（EVH）财务数据对比。点击上方公司名可切换其他公司
CoStar Group的季度营收约是Evolent Health, Inc.的1.9倍（$899.9M vs $468.7M），CoStar Group净利率更高（5.2% vs -91.6%，领先96.7%），CoStar Group同比增速更快（26.9% vs -27.5%），过去两年CoStar Group的营收复合增速更高（17.1% vs -14.4%）
CoStar Group是1987年成立的美国商业地产服务商，总部位于弗吉尼亚州阿灵顿，业务覆盖北美、欧洲地区，为商业地产行业提供信息、分析及营销解决方案，旗下运营CoStar线上数据库、新闻网站及Apartments.com、Homes.com等多个线上平台。
马奎尔健康是一家美国营利性医疗管理企业，目前为森特里奇旗下子公司，核心服务对象为特殊群体，业务聚焦医疗领域多个细分赛道。客户群体涵盖健康保险计划、其他管理式医疗机构、企业、工会、各类军事与政府机构以及第三方管理机构，2021年位列财富美国500强第390名。
CSGP vs EVH — 直观对比
营收规模更大
CSGP
是对方的1.9倍
$468.7M
营收增速更快
CSGP
高出54.4%
-27.5%
净利率更高
CSGP
高出96.7%
-91.6%
两年增速更快
CSGP
近两年复合增速
-14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $899.9M | $468.7M |
| 净利润 | $46.5M | $-429.1M |
| 毛利率 | 78.6% | 20.7% |
| 营业利润率 | 5.5% | -87.1% |
| 净利率 | 5.2% | -91.6% |
| 营收同比 | 26.9% | -27.5% |
| 净利润同比 | -22.2% | -1782.0% |
| 每股收益（稀释后） | $0.12 | $-3.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSGPEVH
| Q4 25 | $899.9M | $468.7M | ||
| Q3 25 | $833.6M | $479.5M | ||
| Q2 25 | $781.3M | $444.3M | ||
| Q1 25 | $732.2M | $483.6M | ||
| Q4 24 | $709.4M | $646.5M | ||
| Q3 24 | $692.6M | $621.4M | ||
| Q2 24 | $677.8M | $647.1M | ||
| Q1 24 | $656.4M | $639.7M |
净利润CSGPEVH
| Q4 25 | $46.5M | $-429.1M | ||
| Q3 25 | $-30.9M | $-20.9M | ||
| Q2 25 | $6.2M | $-19.9M | ||
| Q1 25 | $-14.8M | $-64.6M | ||
| Q4 24 | $59.8M | $-22.8M | ||
| Q3 24 | $53.0M | $-23.1M | ||
| Q2 24 | $19.2M | $1.6M | ||
| Q1 24 | $6.7M | $-17.3M |
毛利率CSGPEVH
| Q4 25 | 78.6% | 20.7% | ||
| Q3 25 | 79.3% | 20.8% | ||
| Q2 25 | 78.5% | 22.6% | ||
| Q1 25 | 79.1% | 21.2% | ||
| Q4 24 | 80.1% | 11.7% | ||
| Q3 24 | 79.7% | 13.0% | ||
| Q2 24 | 80.0% | 16.5% | ||
| Q1 24 | 78.5% | 16.3% |
营业利润率CSGPEVH
| Q4 25 | 5.5% | -87.1% | ||
| Q3 25 | -6.1% | 0.2% | ||
| Q2 25 | -3.5% | -0.3% | ||
| Q1 25 | -5.8% | -0.3% | ||
| Q4 24 | 5.6% | -2.9% | ||
| Q3 24 | 3.4% | -2.6% | ||
| Q2 24 | -2.4% | 1.2% | ||
| Q1 24 | -6.5% | -2.1% |
净利率CSGPEVH
| Q4 25 | 5.2% | -91.6% | ||
| Q3 25 | -3.7% | -4.4% | ||
| Q2 25 | 0.8% | -4.5% | ||
| Q1 25 | -2.0% | -13.4% | ||
| Q4 24 | 8.4% | -3.5% | ||
| Q3 24 | 7.7% | -3.7% | ||
| Q2 24 | 2.8% | 0.2% | ||
| Q1 24 | 1.0% | -2.7% |
每股收益（稀释后）CSGPEVH
| Q4 25 | $0.12 | $-3.76 | ||
| Q3 25 | $-0.07 | $-0.24 | ||
| Q2 25 | $0.01 | $-0.44 | ||
| Q1 25 | $-0.04 | $-0.63 | ||
| Q4 24 | $0.14 | $-0.26 | ||
| Q3 24 | $0.13 | $-0.27 | ||
| Q2 24 | $0.05 | $-0.06 | ||
| Q1 24 | $0.02 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | $151.9M |
| 总债务越低越好 | $140.0M | — |
| 股东权益账面价值 | $8.3B | $415.2M |
| 总资产 | $10.5B | $1.9B |
| 负债/权益比越低杠杆越低 | 0.02× | — |
8季度趋势，按日历期对齐
现金及短期投资CSGPEVH
| Q4 25 | $1.6B | $151.9M | ||
| Q3 25 | $1.9B | $116.7M | ||
| Q2 25 | $3.6B | $151.0M | ||
| Q1 25 | $3.7B | $246.5M | ||
| Q4 24 | $4.7B | $104.2M | ||
| Q3 24 | — | $96.6M | ||
| Q2 24 | — | $101.3M | ||
| Q1 24 | — | $165.1M |
总债务CSGPEVH
| Q4 25 | $140.0M | — | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $1.0B | — |
股东权益CSGPEVH
| Q4 25 | $8.3B | $415.2M | ||
| Q3 25 | $8.6B | $842.2M | ||
| Q2 25 | $8.6B | $896.0M | ||
| Q1 25 | $8.6B | $935.5M | ||
| Q4 24 | $7.6B | $1.0B | ||
| Q3 24 | $7.5B | $1.0B | ||
| Q2 24 | $7.4B | $1.1B | ||
| Q1 24 | $7.3B | $1.0B |
总资产CSGPEVH
| Q4 25 | $10.5B | $1.9B | ||
| Q3 25 | $10.8B | $2.5B | ||
| Q2 25 | $10.5B | $2.5B | ||
| Q1 25 | $10.4B | $2.7B | ||
| Q4 24 | $9.3B | $2.5B | ||
| Q3 24 | $9.1B | $2.5B | ||
| Q2 24 | $9.1B | $2.5B | ||
| Q1 24 | $9.0B | $2.6B |
负债/权益比CSGPEVH
| Q4 25 | 0.02× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $162.1M | $48.8M |
| 自由现金流经营现金流 - 资本支出 | $101.3M | — |
| 自由现金流率自由现金流/营收 | 11.3% | — |
| 资本支出强度资本支出/营收 | 6.8% | — |
| 现金转化率经营现金流/净利润 | 3.49× | — |
| 过去12个月自由现金流最近4个季度 | $123.0M | — |
8季度趋势，按日历期对齐
经营现金流CSGPEVH
| Q4 25 | $162.1M | $48.8M | ||
| Q3 25 | $68.2M | $15.8M | ||
| Q2 25 | $146.5M | $-30.3M | ||
| Q1 25 | $53.2M | $4.6M | ||
| Q4 24 | $94.6M | $-26.2M | ||
| Q3 24 | $100.3M | $18.7M | ||
| Q2 24 | $58.1M | $21.4M | ||
| Q1 24 | $139.6M | $4.9M |
自由现金流CSGPEVH
| Q4 25 | $101.3M | — | ||
| Q3 25 | $-5.5M | — | ||
| Q2 25 | $27.7M | — | ||
| Q1 25 | $-500.0K | — | ||
| Q4 24 | $25.2M | — | ||
| Q3 24 | $40.2M | — | ||
| Q2 24 | $-14.7M | — | ||
| Q1 24 | $-237.1M | — |
自由现金流率CSGPEVH
| Q4 25 | 11.3% | — | ||
| Q3 25 | -0.7% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | -2.2% | — | ||
| Q1 24 | -36.1% | — |
资本支出强度CSGPEVH
| Q4 25 | 6.8% | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | 15.2% | — | ||
| Q1 25 | 7.3% | — | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | 8.7% | — | ||
| Q2 24 | 10.7% | — | ||
| Q1 24 | 57.4% | — |
现金转化率CSGPEVH
| Q4 25 | 3.49× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 23.63× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.58× | — | ||
| Q3 24 | 1.89× | — | ||
| Q2 24 | 3.03× | 13.42× | ||
| Q1 24 | 20.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSGP
| Co Star | $503.8M | 56% |
| Other | $283.0M | 31% |
| Loop Net | $94.7M | 11% |
EVH
| Commercial And Other Customers | $147.9M | 32% |
| Medicare Customers | $111.2M | 24% |
| Specialty Technology And Services Suite | $95.7M | 20% |
| Administrative Service | $55.8M | 12% |
| Cases | $47.7M | 10% |
| Related Party | $4.5M | 1% |
